Johnson & Johnson ran 'cunning' scheme to market opioids, attorney says

Oklahoma state attorney general is suing company for $17bn, to fund treatment and offset other costs of the opioid epidemic

The pharmaceutical giant Johnson & Johnson ran a “cunning, cynical and deceitful scheme” to mass-market opioid painkillers that created the biggest drug epidemic in US history, Oklahoma’s attorney general alleged in closing arguments on Monday in the first major industry trial over the crisis.

The state attorney general, Mike Hunter, is suing Johnson & Johnson for $17bn, to fund treatment and offset other costs of the epidemic in Oklahoma.

Judge Thad Balkman is expected to deliver a verdict next month. It will be closely watched, with hundreds of other lawsuits against drug makers, distributors and pharmacy chains expected to come to federal court.

Balkman was presented with two very different versions of the role played by Johnson & Johnson in an epidemic in which more than 400,000 people have died over the past two decades.

Hunter placed the company at the heart of a conspiracy by the drug industry that caused opioid prescribing to surge far beyond any other country, with one prescription being written for every American adult at its peak, driving addiction and death.

Johnson & Johnson, he said, was a “kingpin” building a “billion-dollar pain franchise” because it made money from the entire length of the production chain, from a poppy growing operation in Australia that supplied 60% of the drug used in opioid manufacturing in the US through to the sale of its own high-strength painkillers.

“What is truly unprecedented here,” he said, “is the conduct of these defendants in embarking on a cunning, cynical and deceitful scheme to create and feed the need for opioids, engineer a mutant poppy to amplify the need they created, overstate the effectiveness and minimise the risk of these drugs, and to oversupply the addictive drugs that have devastated Oklahoma communities and wrecked countless Oklahoma families.”

The state said Johnson & Johnson joined other drug makers in funding a spider’s web of ostensibly independent medical organisations to influence health policy and pressure doctors to prescribe opioids with false claims that the drugs were less addictive and more effective in the long term treatment of chronic pain even though there was no clinical evidence for either assertion.

Hunter said Johnson & Johnson was a commercial rival but also a close collaborator with another major opioid maker accused of driving the epidemic, Purdue Pharma.

Purdue was convicted of a criminal offence in 2007 over illegally marketing its drug OxyContin as safer and more effective than it was. Hunter also sued Purdue but it settled out of court for $270m before the trial.

Another state lawyer, Brad Beckworth, said Johnson & Johnson brushed aside warnings from history and experts about the risks of addiction from opioids, and ignored the maxim that “if you oversupply people will die”.

“They engaged on a path to market opioid drugs as safer than they are and more effective than they are for everyday pain,” he said.

“They worked hand in hand with Purdue to make it happen. And then they engaged with all of their pharmaceutical industry brothers and all of the associations they funded and they coopted to spread this lie that has put us right where we are today.”

Johnson & Johnson sidestepped many of the specific accusations as it sought to persuade the judge the state was trying to make it a scapegoat. It urged Balkman to focus on the much narrower issue of whether the company’s drugs caused addiction and death in Oklahoma.

Johnson & Johnson’s lawyer, Larry Ottaway, said it was no more than a bit player that sold relatively few opioids in the state. He maintained that the company was addressing a desperate need from people living with debilitating long-term pain with medicines regulated by the Food and Drug Administration and even bought by Oklahoma’s health services.

“This is not a free market,” he said. “The supply is regulated by the government.”

Ottaway scoffed at the notion that doctors were influenced by the company’s marketing into prescribing opioids to people who did not need them.

“These are tough, tough decisions,” he said. “To treat patients in pain with opioids. To balance access against risk. There are not easy answers,” he said.

Balkman’s verdict is likely to have national repercussions. Johnson & Johnson is the first drug company to fight a lawsuit over the opioid epidemic instead of reaching a settlement.

Other firms facing a slew of legal actions by states, municipalities and counties across the US will be looking to see if the judge has been persuaded by Hunter’s argument that the firm was influential in driving up prescribing and therefore bears a responsibility for overdoses and deaths.

If he rules against Johnson & Johnson, that might discourage other opioid makers and distributors from fighting it out in court.


Chris McGreal

The GuardianTramp

Related Content

Article image
Judge dismisses Johnson & Johnson's request to toss out lawsuit over opioids crisis
Oklahoma judge says state presented sufficient evidence alleging that the company played a leading role in creating the epidemic

Chris McGreal

08, Jul, 2019 @7:26 PM

Article image
Johnson & Johnson faces multibillion opioids lawsuit that could upend big pharma
Oklahoma is holding the drug giant with the family-friendly image responsible for its addiction epidemic

Chris McGreal in Kansas City

23, Jun, 2019 @6:00 AM

Article image
Lawsuits, payouts, opioids crisis: what happened to Johnson & Johnson?
The household name has been hit in recent years with product misfires and court judgments challenging public trust and investor faith

Edward Helmore in New York

18, Oct, 2019 @6:00 AM

Article image
Johnson & Johnson boosted opioid sales via 'cynical brainwashing', court hears
Drug giant accused of deceptive marketing conspiracy in civil suit that says J&J was ‘kingpin’ of public health emergency

Chris McGreal in Norman, Oklahoma

28, May, 2019 @10:37 PM

Article image
‘Johnson & Johnson helped fuel this fire’ – now it’s out of the opioids business
Whether the pharmaceutical giant jumped or was pushed, its New York deal is a significant sign of the way the wind is blowing

Chris McGreal

27, Jun, 2021 @6:00 AM

Article image
Sackler family want to settle opioids lawsuits, lawyer says
Owners of Purdue Pharma face more than 2,000 lawsuits by officials who blame prescription opioids for sparking drug crisis

Joanna Walters and agency

25, Apr, 2019 @5:00 AM

Article image
Artist Nan Goldin stages opioids protest in Metropolitan Museum Sackler Wing
New York Big Pharma demonstration sees activists dump specially made bottles in moat around Egyptian Temple of Dendur

Joanna Walters in New York

11, Mar, 2018 @12:47 PM

Article image
Massive lawsuit says Sackler family broke laws to profit from opioids
Group of more than 500 cities, counties and tribes accuses family of helping to create ‘worst drug crisis’ in US history

Joanna Walters in New York

22, Mar, 2019 @5:00 AM

Article image
Drug makers conspired to worsen the opioid crisis. They have blood on their hands | Chris McGreal
Johnson & Johnson and others profited from addiction and death – and yet they still don’t think they’ve done anything wrong

Chris McGreal

29, Aug, 2019 @1:57 PM

Article image
Purdue Pharma agrees $12bn settlement in opioids case, plaintiffs' lawyers say
Offer by company and Sackler family valued at up to $12bn, with company to fight opponents of deal in bankruptcy proceedings

Guardian staff and agencies

11, Sep, 2019 @8:14 PM